Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours Β· Estimated delivery Aug 14 - Aug 19
The Regulatory Background In late 2023, the FDA placed 19 widely used peptides on its Category 2 restricted list, effectively barring compounding pharmacies from preparing them
No phase 1, phase 2, or phase 3 clinical trials have been conducted
GHK alone has limited biological activity
Key mechanisms of action include: Fibroblast activation Suppression of collagen-degrading enzymes Reduced inflammatory cytokines Enhanced granulation tissue formation Improved angiogenesis In ischemic wound models, injectable GHK-Cu restored fibroblast function and significantly accelerated skin repair compared to controls
These in vitro results demonstrated that H2O2 induces Leydig cell senescence, accompanied by FOXO4 nuclear translocation and activation of senescence pathways
Nausea, GI upset, or a temporary fishy body odor at high choline exposure
